Chemed Corporation
CHE
$403.47
-$4.41-1.08%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 639.34M | 624.90M | 618.80M | 646.94M | 639.99M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 639.34M | 624.90M | 618.80M | 646.94M | 639.99M |
| Cost of Revenue | 414.17M | 427.99M | 434.11M | 430.53M | 405.88M |
| Gross Profit | 225.17M | 196.91M | 184.69M | 216.41M | 234.12M |
| SG&A Expenses | 102.80M | 105.78M | 100.32M | 105.59M | 104.25M |
| Depreciation & Amortization | 16.33M | 16.23M | 16.26M | 16.02M | 15.83M |
| Other Operating Expenses | -225.00K | 148.00K | 26.00K | 51.00K | -288.00K |
| Total Operating Expenses | 533.07M | 550.15M | 550.71M | 552.19M | 525.67M |
| Operating Income | 106.26M | 74.75M | 68.08M | 94.76M | 114.32M |
| Income Before Tax | 105.45M | 83.54M | 71.12M | 95.67M | 120.12M |
| Income Tax Expenses | 28.69M | 19.31M | 18.62M | 23.92M | 29.80M |
| Earnings from Continuing Operations | 76.75M | 64.24M | 52.49M | 71.76M | 90.32M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 76.75M | 64.24M | 52.49M | 71.76M | 90.32M |
| EBIT | 106.26M | 74.75M | 68.08M | 94.76M | 114.32M |
| EBITDA | 118.29M | 90.98M | 84.34M | 110.78M | 125.86M |
| EPS Basic | 5.48 | 4.46 | 3.60 | 4.91 | 6.08 |
| Normalized Basic EPS | 4.96 | 3.63 | 3.05 | 4.09 | 5.07 |
| EPS Diluted | 5.48 | 4.46 | 3.57 | 4.86 | 6.03 |
| Normalized Diluted EPS | 4.95 | 3.62 | 3.02 | 4.05 | 5.03 |
| Average Basic Shares Outstanding | 13.99M | 14.39M | 14.59M | 14.62M | 14.85M |
| Average Diluted Shares Outstanding | 14.01M | 14.41M | 14.70M | 14.76M | 14.99M |
| Dividend Per Share | 0.60 | 0.60 | 0.50 | 0.50 | 0.50 |
| Payout Ratio | 11.07% | 13.47% | 13.75% | 10.21% | 8.30% |